Abstract The development of multitarget small molecules (MSMs) has emerged as a powerful strategy for the treatment of multifactorial diseases such as cancer. Glioblastoma is the most prevalent and malignant primary brain tumor in adults. which is characterized by poor prognosis and a high heterogeneity. Current standards of treatment present limited effectiveness. https://www.ealisboa.com/limited-stock-Purple-House-Arrethe-Bush-Balm-Soap-quick-super/